Introduction
Oral sotalol initiation requires a multiple-day, inpatient admission to
monitor for QT prolongation during loading. A one-day intravenous (IV)
sotalol loading protocol was approved by the FDA in March 2020, but
limited data on clinical use and administration currently exists. This
study describes implementation of an IV sotalol protocol within an
integrated health system, provides initial efficacy and safety outcomes,
and examines length of stay compared to oral sotalol initiation.